Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: Findings from a large case series with long-term follow-up

Journal of Pathology

Volumn 223, Issue 3, 2011, Pages 358-365

  Mohammed, Rabab A A ^a,b   Martin, Stewart G ^a   Mahmmod, Ali M ^a   MacMillan, R Douglas ^a   Green, Andrew R ^a   Paish, Emma C ^a   Ellis, Ian O ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Assiut University   (Egypt)

Author keywords

Lymph node negative breast cancer; Lymphovascular invasion; Podoplanin; Prognosis

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; PODOPLANIN;

ADULT; AGED; ARTICLE; BLOOD VASCULAR INVASION; BREAST CARCINOMA; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC VASCULAR INVASION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; STAINING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD VESSELS; BREAST NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650602577     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2810     Document Type: Article

References (26)

1. Mohammed RA, Martin SG, Gill MS, et al., Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol 2007; 31: 1825-1833.
2. Braun S, Pantel K, Muller P, et al., Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000; 342: 525-533. (Pubitemid 30117892)
3. Fisher B, Jeong JH, Bryant J, et al., Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet 2004; 364: 858-868. (Pubitemid 40089466)
4. Harbeck N, Jakesz R,. St. Gallen 2004 breast cancer treatment consensus report. Breast Care 2007; 2: 130-134. (Pubitemid 47014392)
5. Galea MH, Blamey RW, Elston CE, et al., The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992; 22: 207-219.
6. Rakha EA, El-Sayed ME, Green AR, et al., Prognostic markers in triple-negative breast cancer. Cancer 2007; 109: 25-32. (Pubitemid 46120191)
7. Abd El-Rehim DM, Pinder SE, Paish CE, et al., Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004; 203: 661-671. (Pubitemid 38714103)
8. Rakha EA, Putti TC, Abd El-Rehim DM, et al., Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 2006; 208: 495-506.
9. Abd El-Rehim DM, Ball G, Pinder SE, et al., High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 2005; 116: 340-350. (Pubitemid 40993329)
10. Madjd Z, Spendlove I, Pinder SE, et al., Total loss of MHC class I is an independent indicator of good prognosis in breast cancer. Int J Cancer 2005; 117: 248-255. (Pubitemid 41377445)
11. Rakha EA, El-Sheikh SE, Kandil MA, et al., Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol 2008; 39: 857-865.
12. Stacker SA, Achen MG, Jussila L, et al., Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002; 2: 573-583. (Pubitemid 37328924)
13. Colleoni M, Rotmensz N, Maisonneuve P, et al., Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 2007; 18: 1632-1640. (Pubitemid 47506249)
14. Mohammed RA, Ellis IO, Lee AH, et al., Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms. Histopathology 2008; 55: 1-9.
15. Lee AH, Pinder SE, Macmillan RD, et al., Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 2006; 42: 357-362. (Pubitemid 43132891)
16. de Mascarel I, Bonichon F, Durand M, et al., Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. Eur J Cancer 1998; 34: 58-65. (Pubitemid 28123381)
17. Pinder SE, Ellis IO, Galea M, et al., Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 1994; 24: 41-47. (Pubitemid 24223138)
18. Viale G, Giobbie-Hurder A, Gusterson BA, et al., Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. Ann Oncol 2010; 21: 245-254.
19. Ejlertsen B, Jensen MB, Rank F, et al., Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 2009; 101: 729-735.
20. Debled M, Mascarel Id, Brouste Vo, et al., Re: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 2010; 102: 275-276.
21. Mohammed RA, Green A, El-Shikh S, et al., Prognostic significance of vascular endothelial cell growth factors A, C and D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 2007; 96: 1092-1100. (Pubitemid 46608319)
22. Rabban JT, Chen YY,. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma. Hum Pathol 2008; 39: 175-183.
23. Fitzgibbons PL, Page DL, Weaver D, et al., Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 966-978.
24. Goldhirsch A, Wood WC, Gelber RD, et al., Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003; 21: 3357-3365. (Pubitemid 46606270)
25. Goldhirsch A, Glick JH, Gelber RD, et al., Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16: 1569-1583. (Pubitemid 41511089)
26. Lauria R, Perrone F, Carlomagno C, et al., The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 1995; 76: 1772-1778.